# Mauritius Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Mauritius HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Mauritius (MUS)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $9.1M
- Products: 20
- Buyer markets: 26
- Average CAGR: +21.4%
- Global sector size: $453.7B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $288.6B | $1.7M | $102.1B | +0.7% | 20 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $23.6B | $26.6K | $13.5B | +22.3% | 8 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $24.4B | $1.9M | $12.8B | +104.6% | 5 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $25.4B | $709.7K | $10.9B | +11.8% | 8 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $28.4B | $1.1M | $10.5B | +216.6% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $19.7B | $6.8K | $8.8B | -4.1% | 6 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $11.9B | $2.9M | $7.2B | +13.4% | 6 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $5.4B | $83.9K | $6.7B | +1.3% | 2 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $5.1B | $106.1K | $4.2B | +16.3% | 2 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.9B | $419.1K | $2.5B | +19.7% | 3 | +0.0% |
| HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $2.4B | $9.7K | $2.0B | -31.1% | 1 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $2.2B | $1.9K | $1.8B | -3.5% | 1 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $3.7B | $32.9K | $1.5B | -11.2% | 2 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $484.8 | $1.2B | -5.9% | 1 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $1.4B | $86.6K | $1.2B | +77.9% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $471.7 | $1.1B | +19.2% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $7.9 | $990.0M | -20.7% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $119.8 | $803.3M | -9.7% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $1.0B | $17.8K | $764.1M | +2.1% | 1 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $185.0 | $640.9M | -29.2% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $45.7B calculated opportunity across 12 products.
- Switzerland, Liechtenstein (CHE): $36.6B calculated opportunity across 4 products.
- China (CHN): $16.0B calculated opportunity across 6 products.
- Germany (DEU): $13.6B calculated opportunity across 7 products.
- France (FRA): $11.6B calculated opportunity across 8 products.
- Netherlands (NLD): $10.5B calculated opportunity across 2 products.
- Spain (ESP): $8.1B calculated opportunity across 4 products.
- Belgium (BEL): $7.9B calculated opportunity across 2 products.
- Canada (CAN): $6.9B calculated opportunity across 4 products.
- United Kingdom (GBR): $6.4B calculated opportunity across 4 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.
- Japan (JPN): $4.4B calculated opportunity across 2 products.

## Growth stars

- HS 300215: +216.6% average CAGR, $10.5B calculated opportunity.
- HS 300212: +104.6% average CAGR, $12.8B calculated opportunity.
- HS 300220: +77.9% average CAGR, $1.2B calculated opportunity.
- HS 382499: +22.3% average CAGR, $13.5B calculated opportunity.
- HS 300290: +19.7% average CAGR, $2.5B calculated opportunity.
- HS 321590: +19.2% average CAGR, $1.1B calculated opportunity.
- HS 300439: +16.3% average CAGR, $4.2B calculated opportunity.
- HS 330300: +13.4% average CAGR, $7.2B calculated opportunity.
- HS 330499: +11.8% average CAGR, $10.9B calculated opportunity.
- HS 281820: +2.1% average CAGR, $764.1M calculated opportunity.

## Diversification opportunities

- HS 300490: 20 buyer markets, $102.1B calculated opportunity.
- HS 382499: 8 buyer markets, $13.5B calculated opportunity.
- HS 330499: 8 buyer markets, $10.9B calculated opportunity.
- HS 382200: 6 buyer markets, $8.8B calculated opportunity.
- HS 330300: 6 buyer markets, $7.2B calculated opportunity.
- HS 300212: 5 buyer markets, $12.8B calculated opportunity.
- HS 300215: 3 buyer markets, $10.5B calculated opportunity.
- HS 300290: 3 buyer markets, $2.5B calculated opportunity.
- HS 330210: 2 buyer markets, $6.7B calculated opportunity.
- HS 300439: 2 buyer markets, $4.2B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.